GR852181B - - Google Patents

Info

Publication number
GR852181B
GR852181B GR852181A GR850102181A GR852181B GR 852181 B GR852181 B GR 852181B GR 852181 A GR852181 A GR 852181A GR 850102181 A GR850102181 A GR 850102181A GR 852181 B GR852181 B GR 852181B
Authority
GR
Greece
Prior art keywords
pyridones
humans
salts
directed
formula
Prior art date
Application number
GR852181A
Other languages
Greek (el)
English (en)
Inventor
Gerd Dr Hilboll
Ille-Stephanie Doppelfeld
Gerrit Dr Prop
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of GR852181B publication Critical patent/GR852181B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR852181A 1984-09-15 1985-09-09 GR852181B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843433953 DE3433953A1 (de) 1984-09-15 1984-09-15 Neue, eine imidazol-gruppe enthaltende 3,4-dihydro-2(1h)-pyridone und2(1h)-pyridone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
GR852181B true GR852181B (en:Method) 1986-01-10

Family

ID=6245507

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852181A GR852181B (en:Method) 1984-09-15 1985-09-09

Country Status (10)

Country Link
US (1) US4699914A (en:Method)
EP (1) EP0175187B1 (en:Method)
JP (1) JPS6172781A (en:Method)
AT (1) ATE49408T1 (en:Method)
DE (2) DE3433953A1 (en:Method)
DK (1) DK417785A (en:Method)
ES (2) ES8705424A1 (en:Method)
GR (1) GR852181B (en:Method)
PT (1) PT81128B (en:Method)
ZA (1) ZA857059B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743608A (en) * 1986-07-15 1988-05-10 Rorer Pharmaceutical Corporation Pyridone-pyridyl-imidazolyl and triazolyl compounds and their use as cardiotonic agents
US4708958A (en) * 1986-09-24 1987-11-24 G. D. Searle & Co. 6-(imidazolyphenyl)-4-iminopyrimidinones useful as hypotensive agents
US4737511A (en) * 1986-11-03 1988-04-12 Schering A.G. Cardiotonic imidazolylphenylpyrrol-2-ones
WO1997036900A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
DE19627310A1 (de) * 1996-06-27 1998-01-02 Schering Ag Imidazolderivate als Stickstoffmonoxid-Synthase-Inhibitoren
KR100388790B1 (ko) * 1998-03-06 2003-10-04 주식회사 엘지생명과학 파네실전이효소저해제로서유용한피리딘-2-온유도체
PE20060285A1 (es) 2004-03-30 2006-05-08 Aventis Pharma Inc Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
TW200635587A (en) * 2004-12-01 2006-10-16 Kalypsys Inc Inducible nitric oxide synthase dimerization inhibitors
EP1954694A1 (en) * 2005-11-28 2008-08-13 Kalypsys, Inc. Imidazole derivatives as nitric oxide synthase dimerisation inhibitor
AU2012382373A1 (en) 2012-06-12 2014-12-11 Abbvie Inc. Pyridinone and pyridazinone derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790106A (fr) * 1971-10-14 1973-04-13 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
DE3016874A1 (de) * 1980-05-02 1981-11-05 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IL69407A (en) * 1982-08-23 1987-10-20 Warner Lambert Co 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
US4503061A (en) * 1983-07-22 1985-03-05 Warner-Lambert Company Substituted phenyl-pyridinones as cardiotonic agents
IL70169A0 (en) * 1982-11-18 1984-02-29 Sterling Drug Inc 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS6172781A (ja) 1986-04-14
ES8705424A1 (es) 1987-05-01
ES8704927A1 (es) 1987-04-16
DK417785D0 (da) 1985-09-13
PT81128A (en) 1985-10-01
ES546965A0 (es) 1987-05-01
EP0175187B1 (de) 1990-01-10
PT81128B (pt) 1987-10-20
ZA857059B (en) 1986-04-30
EP0175187A1 (de) 1986-03-26
DK417785A (da) 1986-03-16
DE3575300D1 (de) 1990-02-15
DE3433953A1 (de) 1986-03-27
ATE49408T1 (de) 1990-01-15
ES554634A0 (es) 1987-04-16
US4699914A (en) 1987-10-13

Similar Documents

Publication Publication Date Title
US5422370B1 (en) Method of using 2-hydroxypropanoic acid (lactic acid) for the treatment of wrinkles
DE3560531D1 (en) Redox indicators
ZA857270B (en) Tetralin derivatives,their preparation and their use
DE3370626D1 (en) Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation
GR79637B (en:Method)
GR852181B (en:Method)
JPS5716822A (en) Use of antipsychotic and adenosine derivative
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
GR852979B (en:Method)
RO87061B (ro) Procedeu pentru prepararea 2-[2'-hidroxi-3'-(1, 1-dimetilpropilamino)-propoxi]-beta-propiofenonei
GR861169B (en) Method for preparing n-(quinolyl) glycinamide derivatives and their application as psychotropes
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
YU217181A (en) Process for preparing 2-(1,4-benzodioxane-2-ylalkyl)-imidazoles
GR851657B (en:Method)
DE3160118D1 (en) Substituted 1.8-dihydroxy-9-(10h)-anthracenones, process for their preparation and medicines containing these compounds
ES8701161A1 (es) Un procedimiento para preparar derivados de piridiloxi
DE3460024D1 (en) Aminopropanol derivatives of 1-(2-hydroxyphenyl)-3-phenyl propanols, method for their manufacture and therapeutic agents containing these compounds
DE3064276D1 (en) 2-(2-chloro-4-cyclopropyl-phenyl-imino)-imidazolidine, acid addition salts thereof, medicaments based on such compounds and preparation process thereof
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
SG72603A1 (en) Preparation of symmetrical or unsymmetrical disubstituted N-cyanodithioiminocarbonates
AT383811B (de) Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten